Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2837)
All Articles published online
|
Apr 28, 2005 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Pan L, Jia ZS, Chen L, Fu EQ, Li GY. Effect of anti-tuberculosis therapy on liver function of pulmonary tuberculosis patients infected with hepatitis B virus. World J Gastroenterol 2005; 11(16): 2518-2521 [PMID: 15832429 DOI: 10.3748/wjg.v11.i16.2518] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i16/2518.htm |
| Number | Citing Articles |
| 1 |
Huang Wen, Ju Jintao, Fan Qunming, Xiao Lining, Li Zhaoshen. Challenges and prospects in research on military epidemiology. Journal of Medical Colleges of PLA 2010; 25(3): 129 doi: 10.1016/S1000-1948(10)60031-7
|
| 2 |
V. V. Dantsev, R. D. Muchaidze, L. R. Levina, M. G. Spitsyn, V. S. Tokmakov, G. S. Balasanyants. The impact of the infection caused by hepatitis B and C on the characteristics of hepatotoxic reactions in tuberculosis patients. Tuberculosis and Lung Diseases 2020; 98(7): 26 doi: 10.21292/2075-1230-2020-98-7-26-30
|
| 3 |
G. Shelton McMullan, James H. Lewis, David Schlossberg. Tuberculosis of the Liver, Biliary Tract, and Pancreas. Microbiology Spectrum 2017; 5(1) doi: 10.1128/microbiolspec.TNMI7-0025-2016
|
| 4 |
Axel Cyriaque Ambassa, Lionel Ulrich Tiani, Ngounoue Marceline Djuidje, Assam Jean Paul Assam, Généviève Andoseh, Thiomo Diane Kamdem, Fossi Cédric Tchinda, Numfor Leonard Nkah, Kamga Hortense Gonsu, Charles kouanfack, Yone Eric Walter Pefura, Francine Ntoumi, Beng Véronique Penlap. Liver enzyme evaluation and NAT2 polymorphism in patients on anti-tuberculosis and antiretroviral drugs at Jamot Hospital in Yaound-Cameroon. African Journal of Biotechnology 2022; 21(3): 106 doi: 10.5897/AJB2021.17436
|
| 5 |
Tume Christopher Bonglavnyuy. Sero-prevalence of Hepatitis B and C virus and High Risk of Hepatotoxicity among TB/HIV Positive and HIV Negative Population in Western Cameroon. Global Journal of Infectious Diseases and Clinical Research 2017; : 001 doi: 10.17352/2455-5363.000011
|
| 6 |
Chawin Sirinak, Wanitchaya Kittikraisak, Duangporn Pinjeesekikul, Pricha Charusuntonsri, Phinai Luanloed, La-ong Srisuwanvilai, Sriprapa Nateniyom, Somsak Akksilp, Sirirat Likanonsakul, Wanchai Sattayawuthipong, Channawong Burapat, Jay K Varma. Viral hepatitis and HIV-associated tuberculosis: Risk factors and TB treatment outcomes in Thailand. BMC Public Health 2008; 8(1) doi: 10.1186/1471-2458-8-245
|
| 7 |
Mark H. Kuniholm, Jennifer Mark, Malvina Aladashvili, N. Shubladze, G. Khechinashvili, Tengiz Tsertsvadze, Carlos del Rio, Kenrad E. Nelson. Risk factors and algorithms to identify hepatitis C, hepatitis B, and HIV among Georgian tuberculosis patients. International Journal of Infectious Diseases 2008; 12(1): 51 doi: 10.1016/j.ijid.2007.04.015
|
| 8 |
Thomas H. Taylor, Dalia Ibrahim, James H. Lewis. Tuberculosis and Nontuberculous Mycobacterial Infections. 2021; : 372 doi: 10.1128/9781555817138.ch25
|
| 9 |
Christina Chou, Nicolette Veracruz, Amit S. Chitnis, Robert J. Wong. Risk of drug‐induced liver injury in chronic hepatitis B and tuberculosis co‐infection: A systematic review and meta‐analysis. Journal of Viral Hepatitis 2022; 29(12): 1107 doi: 10.1111/jvh.13751
|
| 10 |
Jiangshan Lian, Ping Hu, Yingfeng Lu, Yueying Liu, Xiaoxiao Wang, Yimin Zhang, Hongyu Jia, Yida Yang. Prophylactic antiviral treatment reduces the incidence of liver failure among patients coinfected with Mycobacterium tuberculosis and hepatitis B virus. Virus Research 2019; 270: 197664 doi: 10.1016/j.virusres.2019.197664
|
| 11 |
G. Shelton McMullan, James H. Lewis. Tuberculosis and Nontuberculous Mycobacterial Infections. 2017; : 439 doi: 10.1128/9781555819866.ch27
|
| 12 |
Amir F Khan, Ahsan Sajjad, Dedaar A Mian, Muhammad M Tariq, Usman K Jadoon, Muhammad Abbas, Kinza Shakeel, Nadia Saeed, Kiran Abbas. Co-infection With Hepatitis B in Tuberculosis Patients on Anti-tuberculosis Treatment and the Final Outcome. Cureus 2021; doi: 10.7759/cureus.14433
|
| 13 |
Chun-hui Zhu, Man-zhi Zhao, Guang Chen, Jun-ying Qi, Jian-xin Song, Qin Ning, Dong Xu. Baseline HBV load increases the risk of anti-tuberculous drug-induced hepatitis flares in patients with tuberculosis. Journal of Huazhong University of Science and Technology [Medical Sciences] 2017; 37(1): 105 doi: 10.1007/s11596-017-1702-3
|
| 14 |
Maria de Fátima Silva de Lima, Heloísa Ramos Lacerda de Melo. Hepatotoxicity induced by antituberculosis drugs among patients coinfected with HIV and tuberculosis. Cadernos de Saúde Pública 2012; 28(4): 698 doi: 10.1590/S0102-311X2012000400009
|
| 15 |
Lubiao Chen, Dujing Bao, Lin Gu, Yurong Gu, Liang Zhou, Zhiliang Gao, Yuehua Huang. Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment. BMC Infectious Diseases 2018; 18(1) doi: 10.1186/s12879-018-3192-8
|
| 16 |
G. BUSHNELL, N. L. STENNIS, A. M. DROBNIK, D. C. PROOPS, S. D. AHUJA, K. BORNSCHLEGEL, J. FULD. Characteristics and TB treatment outcomes in TB patients with viral hepatitis, New York City, 2000–2010. Epidemiology and Infection 2015; 143(9): 1972 doi: 10.1017/S0950268814002970
|
| 17 |
Jing Zheng, Mei-Hong Guo, He-Wei Peng, Xiao-Ling Cai, Yun-Li Wu, Xian-E Peng. The role of hepatitis B infection in anti-tuberculosis drug-induced liver injury: a meta-analysis of cohort studies. Epidemiology and Infection 2020; 148 doi: 10.1017/S0950268820002861
|
| 18 |
Getnet Yimer, Getachew Aderaye, Wondwossen Amogne, Eyasu Makonnen, Eleni Aklillu, Lars Lindquist, Lawrence Yamuah, Beniyam Feleke, Abraham Aseffa, Landon Myer. Anti-Tuberculosis Therapy-Induced Hepatotoxicity among Ethiopian HIV-Positive and Negative Patients. PLoS ONE 2008; 3(3): e1809 doi: 10.1371/journal.pone.0001809
|
| 19 |
Ning-Tao Wang, Yi-Shin Huang, Meng-Hsien Lin, Bryan Huang, Chin-Lin Perng, Han-Chieh Lin. Chronic hepatitis B infection and risk of antituberculosis drug-induced liver injury: Systematic review and meta-analysis. Journal of the Chinese Medical Association 2016; 79(7): 368 doi: 10.1016/j.jcma.2015.12.006
|
| 20 |
Mohammed A. Agha, Ibraheim I. El-Mahalawy, Hosam M. Seleem, Mohamed A. Helwa. Prevalence of hepatitis C virus in patients with tuberculosis and its impact in the incidence of anti-tuberculosis drugs induced hepatotoxicity. Egyptian Journal of Chest Diseases and Tuberculosis 2015; 64(1): 91 doi: 10.1016/j.ejcdt.2014.09.009
|
| 21 |
Successful Treatment of HCV/TB co-infected Patient With Sofosbuvir and Daclatasvir: A Case Report. Future Virology 2018; 13(5): 317 doi: 10.2217/fvl-2017-0141
|
| 22 |
Wan Beom Park, Won Kim, Kook Lae Lee, Jae-Joon Yim, Moonsuk Kim, Yong Jin Jung, Nam Joong Kim, Dong Hee Kim, Yoon Jun Kim, Jung-Hwan Yoon, Myoung-don Oh, Hyo Suk Lee. Antituberculosis drug-induced liver injury in chronic hepatitis and cirrhosis. Journal of Infection 2010; 61(4): 323 doi: 10.1016/j.jinf.2010.07.009
|